№ | Code | Indicator name | Price UAH | Date of implementation |
HORMONAL PANEL | ||||
1. Thyroid panel | ||||
1. | 101 | Thyrotropic hormone | 130 | 1 |
2. | 103 | Free triiodothyronine (T3 free) | 130 | 1 |
3. | 105 | Free thyroxin (T4 free) | 130 | 1 |
4. | 106 | Thyroglobulin | 155 | 1 |
5. | 107 | Thyroglobulin Antibodies | 155 | 1 |
6. | 108 | Thyroperoxidase antibodies | 155 | 1 |
7. | 215 | Antibodies to receptors | 380 | Up to 5 |
8. | 502 | Calcitonin | 350 | Up to 5 |
9. | 2001 | Package №1 «Thyroid-General» Free Thyroid (T3 free)Thyroxine free (T4 free) | 350 | 1 |
10. | 2002 | Package №2 «Thyroid-autoimmune» Antibodies to thyroid peroxidase Antibodies to thyroglobulin, Thyroglobulin | 415 | 1 |
11. | 2003 | Package №3 «Thyroid-autoimmune» Antibodies to thyroid peroxidase Antibodies to thyroglobulin, Thyroglobulin (ТГ) Carcinoembryonal antigen ( CEA) (РЕА) | 415 | 1 |
12. | 2004 | Package №4 «Thyroid-screening», Thyroxine free (T4 free), Antibodies to thyroperoxidase | 370 | 1 |
13. | 2034 | Package №34 «Thyroid-1», Thyroxine free (T4 free), Free thryroxin (T3 free) Antibodies to thyroperoxidase | 490 | 1 |
14. | 2038 | Package №38 «Thyroid-1», Thyroxine free (T4 free), Antibodies to therioglobulin | 370 | 1 |
2.Reproductive panel | ||||
15. | 110 | Luteinizing hormone (LH) | 145 | 1 |
16. | 111 | Follicle stimulating hormone (FSH) | 145 | 1 |
17. | 112 | Prolactin | 145 | 1 |
18. | 113 | Progesterone | 145 | 1 |
19. | 114 | Testosterone general | 145 | 1 |
20. | 115 | Testosterone free | 250 | from 1 to 3 |
21. | 116 | Estradiol (E2) | 145 | 1 |
22. | 117 | Sex-binding globulin (SHBG) | 155 | from 1 to 3 |
23. | 119 | Anti-Mullerian hormone (AMH MIS) | 490 | Up to 5 |
24. | 126 | Androstenedione | 270 | up to 5 |
25. | 2007 | Package №7 “Reproduction of the first phase” Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin, Estradiol (E2) | 520 | 1 |
26. | 2008 | Package № 8 «Reproduction of the second phase» Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin, Progesterone | 520 | 1 |
27. | 2009 | Package № 9 «Reproduction - 1» Prolactin, Progesterone, Testosterone total, sex hormone binding globulin (CCO), Free androgen Index | 520 | from 1 to 3 |
28. | 2010 | Package № 10 «Reproduction - 2» Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin, Progesterone, Estradiol (E2), Sex-binding globulin (SBG), General testosterone, Free androgen index | 920 | from 1 to 3 |
29. | 2011 | Package № 11 «Index of free androgen» Sex-binding globulin (SBG), Testosterone total, Index of free androgen | 300 | from 1 to 2 |
30. | 2035 | Package № 35 «Reproduction-3» Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Prolactin | 390 | 1 |
31. | 2042 | Package № 42 «Hyperprolactinemia» Thyrotropic hormone (TSH), free thyroxine (free T4), Prolactin ин | 365 | 1 |
32. | 2059 | Package № 59 «Hyperandrogenism» Testosterone total, 17-alpha-hydroxyprogesterone, dehydroepiandrosterone sulfate (DHEA-C), Sex-binding globulin (SBG), Free androgen Index. | 590 | Up to 5 |
3.Prenatal diagnostics | ||||
33. | 120 | Alpha - fetoprotein (AFP) (14-19 weeks of pregnancy) | 155 | 1 |
34. | 121 | (Plasma protein-A associated with pregnancy (8-14 weeks of pregnancy) | 175 | 1 |
35. | 122 | Free β chorionic gonadotropin (11-14 weeks of pregnancy) | 155 | 1 |
36. | 123 | Free Estriol (E3) (14-40 weeks of pregnancy) | 155 | 1 |
37. | 124 | Chorionic gonadotropin - prenatal diagnostics | 150 | 1 |
38. | 2043 | PRISCA І trimester (10 weeks of pregnancy + 0 days - 13 weeks of pregnancy. + 6 days) (PAPP-A - Pregnancy-Associated Protein-A Plasma, β-hCG free, Calculation of prenatal risk (PRISCA) | 295 | 1 |
39. | 2044 | PRISCA ІI trimester (14 weeks of pregnancy – 19 days of pregnancy, free Estriol, Chorionic gonadotropin, Alpha-Fetoprotein, Prenatal Risk Calculation (PRISCA) | 400 | 1 |
4. Pituitary-atrabiliary capsules indications | ||||
40. | 938 | 17-hydroxyprogesterone | 215 | up to 5 |
41. | 458 | Dehydroepiandrosterone Sulfate (DHEAS -04) | 180 | 1 |
42. | 937 | Adrenocorticotropic hormone (ACTH) | 340 | up to 5 |
43. | 459 | Cortisol | 205 | 1 |
ONCOLOGY PANEL | ||||
44. | 132 | Breast cancer marker (СА 15-3) | 165 | 1 |
45. | 133 | Ovarian cancer marker (СА-125) | 165 | 1 |
46. | 135 | Cancer-embryonic antigen (РЕА, СЕА) | 165 | 1 |
47. | 136 | Prostate-specific antigen free (FPSA) | 150 | 1 |
48. | 137 | Prostate-specific antigen general (Т PSA) | 150 | 1 |
49. | 138 | Alpha Fetoprotein (AFP) | 155 | 1 |
50. | 139 | Chorionic gonadotropin | 150 | 1 |
51. | 723 | Early cancer-specific marker - 4 | 470 | up to 5 |
52. | 2014 | Package №14 « Prostate-specific antigen general (Т PSA) Prostate-specific antigen free (FPSA) , Their relation | 270 | 1 |
53. | 2015 | Package №15 « “Oncological female” Thyroglobulin (TG), Breast cancer marker (CA 15-3), Ovarian cancer marker (CA 125), Cancer-embryonic antigen (CEA) | 570 | 1 |
54. | 2031 | Package No. 31 « “Laboratory Diagnosis of Ovarian Cancer” Early Ovarian Cancer Marker (HE-4), Ovarian Cancer Marker (CA-125), ROMA Index | 570 | up to 5 |
INFECTIOUS PANEL | ||||
1. Hepatitis | ||||
55. | 910 | Hepatitis A virus (HAV), IgM antibodies | 155 | From 1 to 2 |
56. | 912 | Hepatitis B virus (HBV), HBsAg (Australian antigen) | 155 | 1 |
57. | 916 | Hepatitis B virus (HBV), HBcAg total antibodies | 155 | 1 |
58. | 919 | Hepatitis C virus C (HCV), total antibodies | 170 | 1 |
59. | 2045 | Package No. 45 «Hepatitis» Hepatitis A, IgM antibodies, Hepatitis BHBsAg virus (Australian antigen), Hepatitis BHBcAg virus total antibodies, Hepatitis C virus total antibodies | 550 | 1 |
60. | 2046 | Package No. 46 «Hepatitis B virus primary screening», HBsAg (Australian antigen), HBcAg total antibodies | 279 | 1 |
2. TORCH infections | ||||
61. | 141 | Cytomegalovirus (CMV), IgM antibodies | 145 | 1 |
62. | 142 | Cytomegalovirus (CMV), IgG antibodies | 145 | 1 |
63. | 144 | Herpes simplex virus type 2 (HSV), IgG antibodies | 145 | 1 |
64. | 931 | Herpes simplex virus type ½ (HSV), IgG antibodies | 145 | 1 |
65. | 143 | Herpes simplex virus type ½ (HSV), IgM antibodies | 145 | 1 |
66. | 145 | Rubella virus, IgM antibodies | 145 | 1 |
67. | 146 | Rubella virus, IgG antibodies | 145 | 1 |
68. | 147 | Toxoplasma, IgM antibodies | 145 | 1 |
69. | 148 | Toxoplasma, IgG antibodies | 145 | 1 |
70. | 2017 | Package No. 17 "TORCH IgG" before pregnancy; Cytomegalovirus IgG antibodies, Herpes simplex virus 1/2 antibodies type IgG, Toxoplasma IgG antibodies, Rubella virus IgG antibodies | 530 | 1 |
71. | 2018 | Package No. 18 "TORCH IgG" without Rubella virus” before pregnancy; Cytomegalovirus IgG antibodies, Herpes simplex virus 1/2 antibodies type IgG, Toxoplasma IgG antibodies | 390 | 1 |
72. | 2019 | Package No. 19 "TORCH IgG with chlamydia without Rubella virus” before pregnancy; Cytomegalovirus IgG antibodies, Herpes simplex virus 1/2 antibodies type IgG, Toxoplasma IgG antibodies, chlamydia IgG antibodies | 530 | 1 |
73. | 2020 | Package No. 20 "TORCH IgG" Cytomegalovirus IgG antibodies, Toxoplasma IgG antibodies, Rubella virus antibodies IgG | 390 | 1 |
74. | 2021 | Package No. 21 "TORCH IgG" while pregnancy; Cytomegalovirus IgM antibodies, Toxoplasma IgM antibodies, Rubella virus antibodies IgM | 390 | 1 |
75. | 2022 | Package No. 22 "TORCH IgG, IgM with herpes"; Cytomegalovirus IgG and IgM antibodies, Toxoplasma IgG and IgM antibodies, Rubella virus antibodies IgG and IgM, Herpes simplex virus 1/2 antibodies type IgG and IgM | 1040 | 1 |
76. | 2023 | Package No. 23 "TORCH IgG, IgM"; Cytomegalovirus IgG and IgM antibodies, Toxoplasma IgG and IgM antibodies, Rubella virus antibodies IgG and IgM | 780 | 1 |
77. | 2030 | Package No. 30 “Infectious” Cytomegalovirus IgG , Herpes simplex virus 1/2 antibodies type IgG, Epstein-Barr virus (nucleorganic antigen) antibodies IgG | 522 | 1 |
3. Airborne infections | ||||
78. | 308 | Rubella virus antibodies IgM (Measles virus IgM) | 370 | up to 5 |
79. | 309 | Rubella virus antibodies IgG (Measles virus IgG) | 300 | up to 5 |
4. Urogenital infections | ||||
80. | 151 | Chlamydia, antibodies IgG | 145 | 1 |
81. | 157 | Chlamydia, antibodies IgM | 145 | 1 |
82. | 153 | Mycoplasma hominis, antibodies IgG | 145 | 1 |
83. | 155 | Ureaplasma urealiticum, antibodies IgG | 145 | 1 |
84. | 2024 | Package No. 24 Urogenital "Chlamydia IgG antibodies, Ureaplasma urealitikum antibodies IgG, Mycoplasma hominis antibodies IgG | 390 | 1 |
5. Gastroenterological infections | ||||
85. | 161 | Helicobacter pylori, total antibodies | 155 | 1 |
6. Diagnosis of infectious mononucleosis | ||||
86. | 162 | Epstein-Barr virus (nuclear antigen), antibodies IgG | 155 | 1 |
87. | 163 | Antibodies IgG to Epstein-Barr Virus Early Antigen | 165 | up to 5 |
88. | 164 | Antibodies IgG to Epstein-Barr viral capsid antigen | 165 | up to 5 |
89. | 940 | Antibodies IgM to Epstein-Barr viral capsid antigen | 165 | up to 5 |
90. | 527-538 | Epstein-Barr Virus Real-time PCR (Polymerase chain reaction) (blood plasma, saliva, buccal scraping) |
225 | up to 5 |
91. | 528-710 | Epstein-Barr Virus Real-time PCR (Polymerase chain reaction) qualitative determination (blood plasma, saliva, buccal scraping) |
280 | up to 5 |
7. Other infections |
||||
92. | 945 | Borrelia IgG antibodies (Borrelia IgG) | 250 | up to 5 |
93. | 946 | Borrelia IgM antibodies (Borrelia IgM) | 250 | up to 5 |
IMMUNOLOGICAL STUDIES | ||||
1. Allergodiagnosis | ||||
94. | 181 | Total immunoglobulin E (tlgE) | 165 | 1 |
95. | 182 | Inhalation panel:warty birch pollen, gray alder pollen, walnut pollen, oak pollen, meadow timothy grass, rye pollen, wormwood pollen, plantain pollen, D.pteronossinus tick, D.farinae tick, dog epithelium, sea epithelium, horse epithelium, horse epithelium, epithelium of horse hamster, rabbit epithelium, Asp. Fumigatus, Cladosp. Herbarum, Pen.Notatus fungus, Alternia tenuis fungus | 850 | 1 |
96. | 183 | Pediatric Panel: soy, milk, chicken egg protein, crab, shrimp (Atlantic and Pacific), peach, D.pteronossinus tick, D.farinae tick, cockroach, dog epithelium, cat epithelium, Alternia tenuis fungus, alder pollen, birch, ragweed pollen, pollen wormwood, meadow timothy pollen, rye pollen, house dust, total IgE.>; | 850 | 1 |
97. | 184 | Pediatric differentiated panel:milk, casein, alpha-lactalbumin, beta-lactoglobulin, bovine serum albumin, protein and egg yolk, rice, soy, banana, pork, veal, chicken, flour mixture (wheat, rice, barley, oats), baker's yeast, tick D .pteronyssinus and D.farinae, the fungus Cladosporium herbarum and Alternatia alternata, a mixture of pollen (birch, oak), a mixture of pollen (alder, hazel), a mixture of herbs (hedgehog team, shrimp, fescue field, ryegrass, timothy field), total IgE | 850 | 1 |
98. | 185 | Food panel:hazelnuts, peanuts, walnuts, almonds, milk, chicken egg white, chicken yolk, casein, potatoes, celery, carrots, tomato, cod, shrimp, peach, apple, soybean wheat flour, sesame seeds, rye flour | 850 | 1 |
99. | 187 | Atopic Pediatric Panel (30 allergens):Milk, alpha-lactalbumin, beta-lactoglobulin, casein, chicken egg protein, chicken yolk, cod, peanuts, cocoa, soybean, apple, carrot, tomato, flour mixture, chicken, citrus mix, rice, 6 herbs mix, rye pollen , dog epithelium, dog epithelium, cat epithelium, Cladosp.herbarum, Alternaria alternate, Aspergillus fumigatus, D. pteronyssinus, D.farinae, warty birch pollen, wormwood pollen, k202 CCD is an allergen cross-reaction marker. |
950 | 1 |
100. | 188 | Panel milk + gluten:Milk, Alpha-Lactalbumin, Beta-Lactalbumin, Bovine Serum Albumin, Gluten, Casein | 750 | 1 |
2. Identification of allergenspecific Ig E antibodies to individual allergens | ||||
101. | 1 | Fungal mold (Alternaria alternate tenius) Ig E | 140 | up to 7 days |
102. | 2 | Fungal mold (Alternaria fumigatus) Ig E | 140 | up to 7 days |
103. | 3 | Fungal mold (Pencillium notatum) Ig E | 140 | up to 7 days |
104. | 4 | House dust mite (Dermatophagoides farinae) Ig E | 140 | up to 7 days |
105. | 5 | House dust mite (Dermatophagoides pteronyssinus) Ig E | 140 | up to 7 days |
106. | 6 | Ig E Chicken | 140 | up to 7 days |
107. | 7 | Cat (epithelium) Ig E | 140 | up to 7 days |
108. | 8 | Rabbit Meat Ig E | 140 | up to 7 days |
109. | 9 | Pork Ig E | 140 | up to 7 days |
110. | 10 | Dog (epithelium) Ig E | 140 | up to 7 days |
111. | 11 | Dog (wool) Ig E | 140 | up to 7 days |
112. | 12 | Beef Ig E | 140 | up to 7 days |
113. | 13 | Egg protein Ig E | 140 | up to 7 days |
114. | 14 | Egg Yolk Ig E | 140 | up to 7 days |
3. Diagnosis of celiac disease | ||||
115. | 444 | Antibodies to gliadin А | 305 | up to 7 days |
116. | 445 | Antibodies to gliadin G | 305 | up to 7 days |
PARASITIC RESEARCH | ||||
117. | 191 | Giardia, total antibodies | 165 | 1 |
118. | 192 | Ascaris, total antibodies | 170 | 1 |
119. | 160 | Toksokara, total antibodies | 165 | 1 |
120. | 165 | Opisthorch, total antibodies | 165 | from 1 to 2 |
121. | 166 | Echinococcus, total antibodies | 165 | from 1 to 2 |
122. | 167 | Trichinella, total antibodies | 165 | from 1 to 2 |
123. | 193 | Opisthorch, Trichinella, Toksokara, Echinococcus, total antibodies |
595 | from 1 to 2 |
124. | 2064 | Package No. 64 "Parasitic-2" Giardia, ascaris, Toksokara, total antibodies | 450 | 1 |
125. | 2025 | Package No. 25 “Parasitic” feces for helminth eggs Giardia microscopy (Parasept system), Ascaris total antibodies, Giardia total antibodies, Opisthorch, Trichinella, Toxocara, echinococcus total antibodies |
980 | from 1 to 2 |
Bacteriological Examination |
||||
126. | 201 | Eye bacterial cultures with an antibioticogram | 280 | up to 7 |
127. | 202 | Throat bacterial cultures with an antibioticogram | 280 | up to 7 |
128. | 203 | Wound bacterial cultures with an antibioticogram | 280 | up to 7 |
129. | 204 | Sperm bacterial cultures with an antibioticogram | 280 | up to 7 |
130. | 205 | Prostatic fluid bacterial cultures with an antibioticogram | 280 | up to 7 |
131. | 206 | Milk bacterial cultures with an antibioticogram | 280 | up to 7 |
132. | 207 | Blood sterility testing with an antibioticogram | 280 | up to 14 |
133. | 208 | Urogenital discharge bacterial cultures with an antibioticogram | 280 | up to 7 |
134. | 2288 | Urogenital discharge bacterial cultures with an antibioticogram + streptococcus agalactiae (B group) | 300 | up to 7 |
135. | 209 | Bacterial culture sout of nose with an antibioticogram | 280 | up to 7 |
136. | 210 | Bacterial culture feces for dysbacteriosis with an antibioticogram | 390 | up to 10 |
137. | 211 | Urine bacterial culture with an antibioticogram | 280 | up to 7 |
138. | 212 | Sputum examination with an antibioticogram | 280 | up to 7 |
139. | 213 | Ear Bacterial culture with an antibioticogram | 280 | up to 7 |
140. | 509 | Diphtheria Test (BL) | 280 | up to 7 |
BIOCHEMICAL RESEARCH | ||||
1. Clinical chemistry | ||||
141. | 220 | AAT (aspartate aminotransferase) | 55 | 1 |
142. | 221 | ALT (Alanine Aminotransferase) | 55 | 1 |
143. | 222 | Total bilirubin | 55 | 1 |
144. | 223 | Direct bilirubin | 55 | 1 |
145. | 224 | Gamaglutamyl transpeptidase | 55 | 1 |
146. | 225 | Alkaline phosphatase | 55 | 1 |
147. | 227 | Total protein (TP) | 55 | 1 |
148. | 228 | Albumin | 55 | 1 |
149. | 230 | Amylase | 65 | 1 |
150. | 231 | Amylopsin | 65 | 1 |
151. | 232 | Lipase | 70 | 1 |
152. | 239 | Urea | 55 | 1 |
153. | 240 | Creatinine | 55 | 1 |
154. | 241 | Uric acid | 55 | 1 |
155. | 245 | Calcium | 55 | 1 |
156. | 246 | Magnesium | 55 | 1 |
157. | 247 | Phosphorus | 55 | 1 |
158. | 250 | Iron | 55 | 1 |
159. | 2026 | Package No. 26 “Liver tests” AAT (aspartate aminotransferase), ALT (Alanine Aminotransferase), fractional bilirubin, Gamaglutamyl transpeptidase, alkaline phosphatase, albumin, total protein |
390 | 1 |
160. | 2027 | Package No. 27 “Pancreas” lipase, amylase in the blood and urine, Pancreatic amylase in the blood and urine | 290 | 1 |
161. | 2047 | Package No. 47 "kidney tests" creatinine, urea, uric acid, albumin, calcium | 240 | 1 |
2.Urine biochemistry | ||||
162. | 258 | Urine amylase | 65 | 1 |
3.Rheumatism diagnostics | ||||
163. | 253 | C-reactive protein | 70 | 1 |
164. | 254 | Rheumatic factor | 70 | 1 |
165. | 255 | Anti-streptolysin 0 | 70 | 1 |
4.Cardiomarkers | ||||
166. | 878 | Antibodies to cyclic citrulline peptide | 370 | up to 5 |
167. | 954 | Antibodies to Mutated Citrulline Vimentin IgG (Anti-MCV) | 520 | up to 5 |
5. Indicators of lipid metabolism | ||||
168. | 233 | Cholesterin | 70 | 1 |
169. | 234 | Triglycerids | 70 | 1 |
170. | 235 | High Density Lipids | 75 | 1 |
171. | 236 | Low Density Lipids | 75 | 1 |
172. | 2028 | Package No. 28 “Fractional Lipids” cholesterol, triglycerides, HDL (high density lipids), LDL (low density lipids), VLDL (very low density lipids), atherogenic coefficient | 330 | 1 |
6. Indicators of carbohydrate metabolism | ||||
173. | 237 | Glucose | 55 | 1 |
174. | 238 | Glycosylated Hemoglobin (HbA1c) | 150 | 1 |
175. | 267 | Glucose tolerance test | 150 | 1 |
176. | 923 | C-peptide | 150 | 1 |
177. | 924 | Insulin | 150 | 1 |
178. | 304 | HOMA (Homeostasis Model Assessment) Index (Insulin + Blood Glucose) | 190 | 1 |
179. | 2036 | Package No. 36 “Carbohydrate Standard” Glucose, glycated hemoglobin, C-peptide | 319 | 1 |
180. | 2037 | Package No. 37 "Carbohydrate complex" (glucose, glycated hemoglobin, C-peptide, insulin, HOMA index) | 440 | 1 |
7. Indicators of phosphorus-calcium metabolism | ||||
181. | 888 | Vitamin D3 (25-OH) | 350 | up to 3 |
8. Blood type | ||||
182. | 268 | Blood type and Rh factor | 95 | 1 |
183. | 295 | Anti rhesus antibodies | 120 | from 1 to 2 |
9. Antiphospholipid metabolism | ||||
184. | 301 | Antibodies to IgG phospholipids | 250 | up to 5 |
185. | 302 | Antibodies to IgM phospholipids | 250 | up to 5 |
186. | 950 | Lupus anti-coagulant (screening | 250 | up to 5 |
187. | 951 | IgM antibodies to cardiolipin піну | 190 | up to 5 |
188. | 952 | IgG antibodies to cardiolipin | 190 | up to 5 |
10. Diagnosis of anemia | ||||
189. | 920 | Ferritin | 190 | up to 4 |
190. | 921 | Vitamin b12 | 190 | up to 4 |
191. | 922 | Folic acid | 190 | up to 4 |
192. | 971 | Transferin | 190 | up to 4 |
GENERAL CLINICAL DEVELOPMENT | ||||
1. Blood test | ||||
193. | 272 | Complete blood count | 140 | 1 |
194. | 273 | Reticulocyte | 75 | 1 |
2.Urine test | ||||
195. | 274 | Urinalysis | 85 | 1 |
196. | 275 | Nechiporenko’s test (clean catch specimen) | 85 | 1 |
3.Cytologic screening | ||||
197. | 277 | Cervical smears to determine atypical cells (cytology) | 80 | 1 |
198. | 555 | Liquid cytologic CellPrep | 410 | up to 4 |
199. | 278 | Flora vaginal swabbing | 60 | 1 |
200. | 279 | Urethra smear | 60 | 1 |
201. | 280 | Prostatic juice | 60 | 1 |
4.Near-patient testing | ||||
202. | 281 | Syphilis, total antibodies | 100 | 1 |
203. | 283 | Hepatitis B virus (HBV), HBsAg | 130 | 1 |
204. | 284 | Hepatitis C virus, total antibodies | 130 | 1 |
205. | 303 | A quick test for diagnosing multi-infections | 360 | 1 |
5.Other testing | ||||
206. | 286 | Koprogramma | 120 | 1 |
207. | 287 | Analysis of feces for helminth eggs and protozoan cysts (parasept system) | 120 | 1 |
208. | 288 | Enterobiasis scraping | 80 | 1 |
209. | 290 | Fecal occult blood test | 60 | 1 |
210. | 296 | Parasitic fungi scraping | 80 | 1 |
211. | 297 | Demodecosis tests (face or eyelashes) | 80 | 1 |
212. | 270 | Nasocytogram |
158 | up to 4 |
COAGULOGRAM | ||||
213. | 298 | Prothrombin Index | 90 | 1 |
214. | 299 | Activated partial thromboplastin time | 55 | 1 |
215. | 300 | Fibrinogen | 80 | 1 |
GENETIC RESEARCH | ||||
216. | 306 | Genetics of lactose metabolism (test for lactose deficiency) (plasma, buccal scraping) | 450 | up to 7 |
RESEARCH OF IMMUNITY | ||||
217. | 32 | Immunogram (cellular and humoral immunity) | 1500 | up to 7 |
218. | 826 | Immunoglobulin A (IgA) | 165 | up to 3 |
219. | 827 | Immunoglobulin G (IgG) | 165 | up to 3 |
220. | 828 | Immunoglobulin M (IgG) | 165 | up to 3 |
PCR (Polymerase chain reaction) DIAGNOSTICS Polymerase chain reaction | ||||
1. Urogenital infections | ||||
221. | 509-106 | Trichomonas, (Trichomonasvaginalis), Real-Time PCR qualitative determination | 155 | up to 5 |
222. | 510-107 | Gardnerella (Gardnerellavaginalis), PCR Real-Time qualitative determination | 155 | up to 5 |
223. | 511-108 | Chlamydia (Chlamidiatrachomatis), Real-Time PCR | 155 | up to 5 |
224. | 512-499 | Mycoplasma hominis (Mycoplasmahominis), PCR Real-Time qualitative determination | 155 | up to 5 |
225. | 513-109 | Mycoplasma genitalium (Mycoplasmagenitalium), PCR Real-Time qualitative determination | 155 | up to 5 |
226. | 514-110 | Ureaplasma urealiticum (Ureaplasmaurealiticum) and ureaplasma parvum (Ureaplasmaparvum), high-quality PCR | 155 | up to 5 |
227. | 711 | Candida species determination (Candida albicans + crusei + glabrata), Real-Time PCR qualitative determination | 250 | up to 5 |
228. | 516-115 | Gonorrhea (Neisseriagonorrhoeae), Real-Time PCR qualitative determination | 155 | up to 5 |
229. | 536-890 | Package No. 32 Package No. 32 “PCR - 1” Chlamydia trachomatis, Ureaplasma parvum, Ureaplasma urealitikum, Mycoplasma genital PCR Real-Time qualitative determination | 450 | up to 5 |
230. | 537-80 | Package No. 33 "PCR - 2" Chlamydia trachomatis, Ureaplasma perfume, Ureaplasma urealitikum PCR Real-Time qualitative determination | 300 | up to 5 |
2. Papillomovirus infection | ||||
231. | 517-113 | Human papillomavirus (HPV): types 16 and 18, Real-Time PCR qualitative determination for each type | 150 | up to 5 |
232. | 520-705 | Quantification of human papillomavirus (HPV) 12 types by phylogenetic groups (A7 (18,39,45,59), A9 (16,31,33,35,52,58), A5 / A6 (51, 56), PCR Real time | 480 | up to 5 |
233. | 521-706 | Genotyping of human papillomavirus (HPV) 12 types (16.18, 31.33.35.39.45.51.52.56.58.59), Real-Time PCR qualitative determination | 450 | up to 5 |
234. | 332 | Genotyping of human papillomavirus (HPV) 14 types (16,18,31,33,35,39,45,51,52,56,58,59,66,68), PCR quantitation by cutaneous type | 470 | up to 5 |
235. | 522-731 | Genotyping of human papillomavirus (HPV) type 21(6,11,16,18,26,31,33,35,39,44,45,51,52,53,56,58,59,66,68,73, 82), PCR quantification by cutaneous type | 850 | up to 5 |
3. The study of the biocenosis of the urogenital tract | ||||
236. | 524-730 | Femoflor® Screen. studies of the biocenosis of the urogenital tract. Total bacterial mass (quantitatively), Lactobacillus spp. (Quantitatively), Gardnerella vaginalis / Prevotella bivia / Porphyromonas spp. (Quantitatively) Ureaplasma (urealyticum and parvum) (quantitatively), Candida spp. (Qualitative), Mycoplasma hominis (qualitative), Mycoplasma genitalium (qualitative), Trichomonas vaginalis (qualitative), Neisseriagonorrhoeae (qualitative), Chlamydiatrachomatis (qualitative), Herpes simplex virus type 1 and 2 (qualitative), Cytomegalovirus R (qualitative) -time quantitative / qualitative | 750 | up to 5 |
4.TORCH infections | ||||
237. | 525-111 | Cytomegalovirus, PCR Real-Time quantification (scraping, excretion, plasma) (underline as necessary) | 150 | up to 5 |
238. | 526-523 | Toxoplasma, PCR Real-Time qualitative determination (scraping, plasma) (underline as necessary) | 190 | up to 4 |
239. | 529-722 | Herpes simplex virus type 1 and 2 (HSV-1 and 2), high-quality PCR genotyping (scraping, excretion, plasma) (underline as applicable) | 205 | up to 3 |
240. | 530-539 | Varicella-Zoster virus (VZV), PCR qualitative determination | 250 | up to 3 |
5. Hepatitis | ||||
241. | 531-398 | Hepatitis B virus (HBV), Real-Time PCR qualitative determination | 290 | up to 7 |
242. | 532-707 | Hepatitis B virus (HBV), Real-Time PCR quantification | 865 | up to 12 |
243. | 533-399 | Hepatitis C virus (HCV), Real-Time PCR qualitative determination | 290 | up to 7 |
244. | 534-708 | Hepatitis C virus (HCV), Real-Time PCR quantification | 865 | up to 7 |
245. | 333 | Genotyping of hepatitis C virus (5 types: 1a, 1b, 2,3a, 4), Real-Time PCR qualitative determination (plasma) | 610 | up to 7 |
6. Respiratory infections | ||||
246. | 340 | Diagnosis of whooping cough (Bordetella pertusis), paracussis (Bordetella parapertusis), bronchosepticosis (Bordetella bronchiseptica) Real-time PCR | 270 | up to 5 |
SAMPLING | ||||
247. | 91 | Blood sample from the vein, finger |
25 | |
248. | 92 | Culture sampling for investigation | 25 | |
249. | 95 | Demodicosis and parasitic fungiscraping | 25 | |
250. | 96 | Urogenital tract (PCR) sampling) | 30 | |
251. | 97 | Urogenital tract sampling (Culture) |
25 | |
252. | 99 | Liquid cytology sampling |
50 | |
253. | 93 | Nursing care at home (call) | 100 | |
254. | 90 | Material freezing (shelf life 1 month) | 20 |
You may be interested in the information:
Where to get tested? How to get the research result? How to prepare for test?